Jun Proto-Oncogene (JUN) (pSer63) antibody
| Antigen | Jun Proto-Oncogene (JUN) |
| Synonyms | AP1, AP-1, c-Jun, fj36h07, zgc:65863, wu:fj36h07, jun |
| Binding Site |
Alternatives pSer63 |
| Clonality | Monoclonal (2) |
| Host |
Alternatives Mouse |
| Reactivity |
Alternatives Human |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Western Blotting (WB), Immunohistochemistry (Formalin-fixed Sections) (IHC (f)) |
![]() |
7 references available |
| Catalog no. | ABIN967578 |
| Quantity | 0.1 mg (0.25 mg/ml) |
| Price | Product not available in this region. |
| Shipping to |
|
Additional Information
| Alternative name | C-Jun |
| Cross-Reactivity (Details) | Predicted: Mouse, Rat |
| Format | Liquid |
| Isotype | IgG1 |
| Clone | 2 |
| Description |
The activator protein transcription factor (AP-1) was identified as a protein that recognizes specific sequences in the cis-control regions of the SV40 virus and the human metallothionein IIA gene. AP-1 is composed of protein products of two different gene families: jun and fos. The AP-1 transcription factor is either a homodimer of Jun proteins or a heterodimer of Jun and Fos proteins. The transcriptional activity of Jun is enhanced by phosphorylation of serines 63 (S63) and 73 in its activation domain. Phosphorylation at both sites is necessary for stimulating the activating function of Jun. Jun is phosphorylated by JNK protein kinases that are activated by the same signals that potentiate Jun activity. The 2/c-Jun/(S63) monoclonal antibody recognizes the phosphorylated S63 of c-Jun. |
| Characteristics |
1. Since applications vary, each investigator should titrate the reagent to obtain optimal results. 2. Please refer to us for technical protocols. 3. Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing. 4. Source of all serum proteins is from USDA inspected abattoirs located in the United States. |
| Molecular Weight | 39 kDa |
| Comments |
Related Products: ABIN967389 |
Application Details
| Concentration | 0.25 mg/ml |
| Purity | Purified |
| Purification | Purified from tissue culture supernatant or ascites by affinity chromatography. |
| Buffer | Aqueous buffered solution containing BSA, glycerol. |
| Preservative | 0.09% Sodium azide. |
| Storage | Store undiluted at -20°C. |
| Restrictions | For Research Use only |
Images
Publications
| Product |
Smeal, Binetruy, Mercola et al.: "Oncoprotein-mediated signalling cascade stimulates c-Jun activity by phosphorylation of serines 63 and 73." in: Molecular and cellular biology, Vol. 12, Issue 8, pp. 3507-13, 1992 (PubMed).
Lamph, Wamsley, Sassone-Corsi et al.: "Induction of proto-oncogene JUN/AP-1 by serum and TPA." in: Nature, Vol. 334, Issue 6183, pp. 629-31, 1988 (PubMed). Wisdom, Johnson, Moore: "c-Jun regulates cell cycle progression and apoptosis by distinct mechanisms." in: The EMBO journal, Vol. 18, Issue 1, pp. 188-97, 1999 (PubMed). Behrens, Sibilia, Wagner: "Amino-terminal phosphorylation of c-Jun regulates stress-induced apoptosis and cellular proliferation." in: Nature genetics, Vol. 21, Issue 3, pp. 326-9, 1999 (PubMed). Shaulian, Karin: "AP-1 in cell proliferation and survival." in: Oncogene, Vol. 20, Issue 19, pp. 2390-400, 2001 (PubMed). Dunn, Wiltshire, MacLaren et al.: "Molecular mechanism and biological functions of c-Jun N-terminal kinase signalling via the c-Jun transcription factor." in: Cellular signalling, Vol. 14, Issue 7, pp. 585-93, 2002 (PubMed). Weiss, Bohmann: "Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis." in: Cell cycle (Georgetown, Tex.), Vol. 3, Issue 2, pp. 111-3, 2004 (PubMed). |
Alternatives
Alternatives for antigen "Jun Proto-Oncogene (JUN)", type "Antibodies"




Alternatives